Search results
Healthier Together: Postpartum depression can put new moms, babies at risk
KIRO 7 Seattle-Tacoma· 2 hours agoMany doctors and mothers still contend that there’s still a lot of misperceptions and stigma around ...
FDA clears Curio's postpartum depression PDT
NJBIZ· 6 hours agoCurio Digital Therapeutics Inc.’s MamaLife Plus offers a nonpharmaceutical alternative to treating postpartum depression. Princeton-based Curio announced...
A New Treatment Offers Hope to Mothers Battling Postpartum Depression
Denton Record-Chronicle· 4 days agoToday, the term for mothers having anxiety and depression after having a baby is called “postpartum ...
I thought I could beat postpartum depression on my own, but it was beating me
Motherly via Yahoo News· 6 days agoShe very gently told me she thought I should see the doctor before the six-week appointment, and it...
Lipocine Announces Completion of Dosing in Pivotal Study of Postpartum Depression Candidate, LPCN...
The Herald Journal· 2 days agoLipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company, today announced that dosing of subjects has been completed in the pivotal pharmacokinetic (PK) study designed to support a New Drug ...
Small Business - Shelby County Reporter | Shelby County Reporter
The Shelby County Reporter· 10 hours agoPhase 2b clinical trial of GH001 in patients with treatment-resistant depression on track for expected completion of double-blind phase in Q3 2024 and of 6-month open-label ...
Reunion Neuroscience Inc. Announces $103 Million Series A Financing Co-Led by MPM BioImpact and Novo...
Benzinga· 1 day agoReunion Neuroscience Inc., a clinical-stage biopharmaceutical company committed to pushing the boundaries of neuroscience, today announced the close of a $103 million Series A financing co-led ...
Embracing Imperfect Parenting: One mom’s story of maternal mental health
The Post and Courier· 2 days agoAfter her daughter was born, Jenna Clancey found herself facing a reality that was vastly different from the perfect vision she had held for her family. The postpartum months ...
HC Wainwright Cuts Sage Therapeutics (NASDAQ:SAGE) Price Target to $25.00
ETF DAILY NEWS· 5 days agoSage Therapeutics (NASDAQ:SAGE – Free Report) had its target price cut by HC Wainwright from $28.00 to $25.00 in a research report sent to investors on Friday morning, Benzinga reports. They ...
Q2 2024 EPS Estimates for Sage Therapeutics, Inc. Lifted by Analyst (NASDAQ:SAGE)
ETF DAILY NEWS· 3 days agoSage Therapeutics, Inc. (NASDAQ:SAGE – Free Report) – Wedbush upped their Q2 2024 earnings estimates for Sage Therapeutics in a note issued to investors on Thursday, April 25th. Wedbush analyst ...